What is the Asston Pharmaceuticals Ltd share price today?

The share price of BSE:APL-MT on 01 Oct 2026 (as of 15:05:27 IST) is ₹97.4.

What is the BSE:APL-MT 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:APL-MT 52 week high low range shows a high of ₹126.1 and a low of ₹60.

What is the Asston Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Asston Pharmaceuticals Ltd market cap is ₹1064970000.

What is the shareholding pattern of Asston Pharmaceuticals Ltd Stock?

The shareholding pattern of Asston Pharmaceuticals Ltd, as of last reported-on 31 Mar 2026 is: Promoters: 50.66% Foreign Institutional Investors (FII): 1.91% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 47.43% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Asston Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Asston Pharmaceuticals Ltd is 27.5614, and the Price-to-Book (PB) ratio is 0, as on 01 Oct 2026.

Asston Pharmaceuticals Share Price

141.00-2.05 (-1.43%)

+69.68% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.43%

1 Week

-6.45%

1 Month

+43.88%

3 Month

+71.95%

6 Month

+76.38%

YTD

+70.85%

1 Year

+69.68%

5 Year

10 Year

Max

+18.49%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

135.90

90.25

78.00

60.00

High

149.80

153.00

153.40

About

Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under brand ‘Asston’. The company Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

APL-MTNSE

LTP

1W Low

1W High

Market cap (₹)

1776-2.25 (-0.13%)

1720.80

1809.65

4,25,150Cr

10036+321 (3.30%)

9866.35

10080.20

2,66,265Cr

4730+94.85 (2.05%)

4555

4730

1,76,301Cr

2306.1-85.9 (-3.59%)

2252.50

2442

1,25,352Cr

1190-54 (-4.34%)

1182.05

1266.15

1,23,591Cr

1372+21.8 (1.61%)

1337.30

1390.70

1,14,351Cr

1400.1+20.1 (1.46%)

1364.75

1400.60

1,12,474Cr

2533.15+44.4 (1.78%)

2457.35

2539

1,02,315Cr

1701.1+23.3 (1.39%)

1656.90

1724.50

97,757Cr

2015+6 (0.30%)

1989.10

2061.55

92,007Cr

137.95-12.77 (-8.47%)

135.90

153

156Cr

Asston Pharmaceuticals Share Price

141.00-2.05 (-1.43%)

+69.68% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years38%

Last year61%

Compounded Profit Growth

10 years-

5 years-

3 years239%

Last year218%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year72%

Return on Equity

10 years42%

5 years42%

3 years52%

Last year51%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	38%	61%
-	-	239%	218%
-	-	-	72%
42%	42%	52%	51%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

APL-MT

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,780	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
10,003.3	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,689	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,318.1	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,200	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,367.7	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,395.8	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,502.55	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,715	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,020.5	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
141	₹156 Cr	40.44	—	3.83	₹4 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—
₹6 Cr	₹78 L	₹70 L	₹70 L
₹4 Cr	₹6 Cr	₹1 Cr	₹23 L
₹4 Cr	₹6 Cr	₹1 Cr	₹23 L
₹11 Cr	₹6 Cr	₹2 Cr	₹93 L
₹14 L	₹91 L	₹97 L	₹69 L
₹2 Cr	₹72 L	₹85 L	₹25 L
-₹2 L	₹2 L	₹3 L	₹2 L
₹16 L	₹16 L	₹7 L	₹5 L
₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr
—	—	—	—
₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr
₹3 Cr	₹83 L	₹45 L	₹51 L
₹4 Cr	₹5 Cr	₹3 Cr	₹2 Cr
₹2 Cr	₹86 L	₹67 L	₹20 L
₹15 Cr	₹12 Cr	₹10 Cr	₹8 Cr
₹28 Cr	₹20 Cr	₹14 Cr	₹9 Cr
₹7 Cr	₹7 Cr	₹5 Cr	₹3 Cr
—	—	—	—
₹1 Cr	₹1 Cr	₹1 Cr	₹94 L
₹14 L	₹11 L	₹6 L	₹3 L
₹96 L	₹1 Cr	₹1 Cr	₹92 L
₹13 L	₹13 L	₹1 Cr	₹1 Cr
₹0	₹71 L	₹67 L	₹0
₹1 Cr	₹2 Cr	₹3 Cr	₹2 Cr
—	—	—	—
₹72 L	₹1 Cr	₹2 Cr	₹50 L
₹25 Cr	₹16 Cr	₹9 Cr	₹6 Cr
₹20 L	₹64,000	₹12 L	₹14 L
₹1 L	₹0	₹0	₹0
₹2 Cr	₹74 L	₹46 L	₹34 L
₹27 Cr	₹18 Cr	₹11 Cr	₹7 Cr
₹12 Cr	₹6 Cr	₹91 L	-₹18 L
₹28 Cr	₹20 Cr	₹14 Cr	₹9 Cr
₹17	₹82	₹28	₹13
₹17	₹10	₹4	₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹6 Cr	₹2 Cr	₹1 Cr	₹16 L
₹93 L	₹94 L	₹75 L	₹44 L
-₹7 Cr	-₹6 Cr	-₹2 Cr	-₹2 Cr
-₹17 L	-₹3 Cr	-₹30 L	-₹1 Cr
-₹16 L	-₹4 Cr	-₹32 L	-₹1 Cr
₹87 L	-₹54,000	-₹91 L	-₹20,000
-₹51 L	₹4 Cr	₹1 Cr	₹1 Cr
₹19 L	-₹12 L	-₹1 L	₹10 L
₹63,000	₹12 L	₹14 L	₹3 L
₹20 L	₹64,000	₹12 L	₹14 L

Fundamental Ratios

Consolidated

Standalone

No results found

Asston Pharmaceuticals Share Price

141.00-2.05 (-1.43%)

+69.68% past 1 Year

Shareholding summary

Promoters

39.48%

FII

DII

Others

60.52%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Mar 2026	Sep 2025	Jul 2025
39.48%	50.66%	50.66%	50.66%
0.00%	1.91%	6.04%	9.71%
0.00%	0.00%	0.00%	1.43%
0.00%	0.00%	0.00%	0.00%
60.52%	47.43%	43.30%	38.20%

Bulk & block deals

Name

Prashant P Sawant

Prakruti R Pali

Snehlata Manoj Kathotia

Prakruti R Pali

Vanita Anilkumar Kumbhare

Snehlata Manoj Kathotia

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
27 Oct 2026	Purchase	85.67 L	₹140.44	61 K	Bulk	0.716602	BSE
23 Oct 2026	Purchase	59.41 L	₹129.16	46 K	Bulk	0.540388	BSE
01 Sep 2026	Purchase	62.75 L	₹123.04	51 K	Bulk	0.599126	BSE
31 Aug 2026	Purchase	1.24 Cr	₹123.88	1 L	Bulk	1.174757	BSE
31 Aug 2026	Purchase	51.21 L	₹119.10	43 K	Bulk	0.505145	BSE
28 Aug 2026	Purchase	1.85 Cr	₹112.81	1.64 L	Bulk	1.926601	BSE
27 Aug 2026	Purchase	2.49 Cr	₹103.69	2.40 L	Bulk	2.819416	BSE
26 Aug 2026	Purchase	1.32 Cr	₹95.59	1.38 L	Bulk	1.621164	BSE
20 Aug 2026	Sell	56.73 L	₹81.04	70 K	Bulk	0.82233	BSE
20 Aug 2026	Purchase	54.73 L	₹81.68	67 K	Bulk	0.787087	BSE